期刊文献+

血清内脏脂肪素与糖尿病周围神经病变的相关性研究 被引量:9

The relationship between serum visfatin and type 2 diabetic peripheral neuropathy
原文传递
导出
摘要 目的测定糖尿病周围神经病变(DPN)患者血清内脏脂肪素(Visfatin)水平,探讨Visfatin与DPN的相关性。方法选取我科住院的T2DM患者90例,分为T2DM合并周围神经病变组(DPN)58例,T2DM不合并周围神经病变组(Non-DPN)32例。另选正常对照组(NC)30名。测定各组FPG、TG、TC、LDL-C、HDL-C,Fins、Visfatin及肝、肾功能;稳态模型评估胰岛素抵抗指数(HOMA-IR)、胰岛β细胞功能指数(HOMA-β)。结果 Visfatin水平在NC、Non-DPN和DPN组逐渐升高[(141.3±57.5)vs(242.3±58.0)vs(350.1±59.8)pg/ml](P<0.05)。Visfatin水平与病程、WHR、FPG、HbA_1c、TG、胱抑素C(Cys-C)、UAER呈正相关(r分别为0.323、0.128、0.449、0.325、0.172、0.327、0.329,P<0.05),与HOMA-β呈负相关(r=-0.497,P<0.01);Logistic回归分析显示,Visfatin是影响DPN发生的独立危险因素。结论血清Visfatin水平的升高可能与DPN有关。 Objective To detect the serum visfatin levels in type 2 diabetes(T2DM) patients with or without peripheral neuropathy,and to explore the relationship between visfatin and diabetic peripheral neuropathy(DPN).Methods 90 patients with T2 DM were divided into T2 DM with DPN group(DPN group,n = 58) and without DPN group(Non-DPN group,n = 32).30 healthy people were selected as normal controls(NO.Biochemical parameters were measured,including fasting blood glucose(FPG),triglyceride(TG),total cholesterol(TC),low density lipoprotein cholesterol(LDL-C),high density lipoprotein cholesterol(HDL-C),and hemoglobin Alc(HbA_1c),fasting insulin(FIns) and liver and kidney function.The homeostasis model assessment(HOMA) was used to estimate insulin resistance index(IR)and islet β-cell function(HOMA-β).Serum visfatin levels were determined by method of ELISA.Results DPN group had the highest levels of serum visfatin,followed by Non-DPN group,and then NC group[(141.3±57.5) to(242.3 ± 58.0) vs(350.1 ± 59.8)pg/ml](P〈0.05).Pearson relation analysis showed that serum visfatin level was positively correlated with diabetic duration,WHR,FPG,HbA_1c,Cys-C,and UAER(r = 0.323,0.128,0.449,0.325,0.172,0.327,and 0.329,respectively,P〈0.05),and negatively correlated with HOMA-β(r=- 0..497,P〈0.01).Logistic regression analysis showed that serum visfatin was independent risk factors for DPN in patients with T2 DM.Conclusion The high levels of serum visfatin may be related to the process of DPN.
出处 《中国糖尿病杂志》 CAS CSCD 北大核心 2016年第6期524-527,共4页 Chinese Journal of Diabetes
基金 贵州省科技合作项目[黔科合区域合(2010)7004号] 贵州省科技支撑计划项目社会发展攻关项目[黔科合SY字合(2013)3033号]
关键词 内脏脂肪素 糖尿病 2型 糖尿病周围神经病变 Visfatin Diabetes mellitus type 2 Diabetic peripheral neuropathy(DPN)
  • 相关文献

参考文献7

  • 1陈永生.2型糖尿病视网膜病变与visfatin和SAA的相关性研究[J].国际眼科杂志,2012,12(1):39-42. 被引量:9
  • 2Nather A, Lin W K, Aziz Z, et al. Assessment of sensory neu- ropathy in patients with diabetic foot problems. Diabetic foot ankle, 2011,2 : 3402.
  • 3Sun ZJ, Lei H, Zhang ZE. Pre-B Cell colony enhancing factor (PBEF), a eytokine with multiple physiological Functions. Cy- tokine Growth Factor Rev, 2013,24 : 433-442.
  • 4Kirsty C, McGee, Alison L, et al. Visfatin is regulated by rosigl- itazone in type 2 diabetes mellitus and influenced by NF-~B and JNK in human abdominal subcutaneous adipocytes. PLoS One, 2011,6:e20287.
  • 5黄丽芳,荣海钦,季虹,孙海玲,王庆美.2型糖尿病患者治疗后血清内脏脂肪素水平的变化及其与炎症因子的关系[J].中国糖尿病杂志,2010,18(6):424-426. 被引量:5
  • 6Karvestedt L,Martensson E, Grill V, et al. The prevalence o{ peripheral neuropathy in a population-based study of patients with type 2 diabetes in Sweden. J Diabetes Complications, 2011,25..97-106.
  • 7Kang YS,Bae MK, Kim JY, et al. Visfatin induces neurite out- growth in PC12 cells via ERK1/2 signaling pathway. Neuro- science letters, 2011,504 : 121-126.

二级参考文献24

  • 1Curat CA,Wegner V,Sengenes C,et al.Macrophages in human visceral adipose tissue increased accumulation in obesity and a source of resistin and visfatin.Diabetologia,2006,49:744-747.
  • 2Bo S,Ciccone G,Baldi I,et al.Plasma visfatin concentrations after a lifestyle intervention were directly associated with inflammatory markers.Nutr Metab Cardiovasc Dis,2009,19:423-430.
  • 3Tan BK,Chen J,Digby JE,et al.Increased visfatin mRNA and protein levels in adipose tissue and adipocytes in women with polycystic ovary syndrome(PCOS);parallel increase in plasma visfatin.J Clin Endocrinol Metab,2006,91:5022-5028.
  • 4Samara A,Pfister M,Marie B,et al.Visfatin,low-grade inflammation and body mass index(BMI).Clin Endocrinol(oxf),2008,69:568-574.
  • 5Wang P,Xu TY,Guan YF,et al.Perivascular adipose tissue-derived visfatin is a vascular smooth musecle cell growth factor:role of nicotinamide mononucleotide.Cardiovasc Res 2009;81(2):370-380.
  • 6Dahl TB,Yndestad A,Skjelland M,et al,Incerased expression of visfatin in macrophages of human unstable carotid and coronay atherosclerosis:possible role in inflammation and plaque destabilization.Circulation 2007;115(8):972-980.
  • 7Cheng KH,Chu CS,Lee KT,et al.Adipocytokines and proinfiammatory mediators from abdominal and epicardial adipose tissue in patirets with coronary artery disease.Int J Obes(Load) 2008;32(2):268-274.
  • 8Spiroglou SG,Kostopoulos CG,Varakis JN,et al.Adipokines in periaortic and epicardial adipose tissue:differential expression and relation to atherosclerosis.J Atheroscler Thromb 2010;17(2):115-130.
  • 9Liu SW,Qiao SB,Yuan JS,et al.Association of plasma visfatin levels with inflammation,atherosclerosis and acute coronary syndromes(ACS) in humans.Clin Endocrinol(Oxf) 2009;71(2):202-207.
  • 10Kostapanos MS,Derdemezis CS,Filippatos TD,et al.Effect of rosuvastatin treatment on plasma visfatin levels in patients with primary hyperlipidemia.Eur J Pharmacol 2008;578(2-3):249-252.

共引文献12

同被引文献87

引证文献9

二级引证文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部